Literature DB >> 2353575

CSF immune variables in patients with narcolepsy.

S Fredrikson1, B Carlander, M Billiard, H Link.   

Abstract

Cerebrospinal fluid (CSF) and serum from 15 patients with narcolepsy were examined regarding presence of oligoclonal bands on isoelectric focusing, IgG index elevation as indicator of intrathecal IgG production and CSF/serum albumin ratios. Two of 15 patients (13%) showed oligoclonal IgG bands in CSF, one of whom had increased IgG index. Slight disturbance of blood-brain-barrier function as reflected by elevated CSF/serum albumin ratios was present in 4 other patients. The frequency of oligoclonal IgG bands in CSF from patients with narcolepsy is within the range of what is found in other neurological, non-inflammatory diseases. These findings do not support the hypothesis of an immune-mediated pathogenesis of narcolepsy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2353575     DOI: 10.1111/j.1600-0404.1990.tb00978.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

1.  [The neurotransmitter, hypocretin. An overview].

Authors:  C Baumann; C Bassetti
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

Review 2.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

Review 3.  Genetics of narcolepsy and other sleep disorders.

Authors:  E Mignot
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

4.  Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment.

Authors:  E Mignot; C Wang; C Rattazzi; C Gaiser; M Lovett; C Guilleminault; W C Dement; F C Grumet
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in canine model.

Authors:  M Tafti; S Nishino; M S Aldrich; W Liao; W C Dement; E Mignot
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

6.  Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset.

Authors:  Birgitte Rahbek Kornum; Fabio Pizza; Stine Knudsen; Giuseppe Plazzi; Poul Jennum; Emmanuel Mignot
Journal:  Brain Behav Immun       Date:  2015-03-11       Impact factor: 7.217

Review 7.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

8.  IgH (mu-switch and gamma-1) region restriction fragment length polymorphism in human narcolepsy.

Authors:  S M Singh; C F George; R N Ott; C Rattazzi; C Guilleminault; W C Dement; E Mignot
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

9.  Neuronal degeneration in canine narcolepsy.

Authors:  J M Siegel; R Nienhuis; S Gulyani; S Ouyang; M F Wu; E Mignot; R C Switzer; G McMurry; M Cornford
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

Review 10.  Hypocretin/orexin and narcolepsy: new basic and clinical insights.

Authors:  S Nishino; M Okuro; N Kotorii; E Anegawa; Y Ishimaru; M Matsumura; T Kanbayashi
Journal:  Acta Physiol (Oxf)       Date:  2009-06-25       Impact factor: 6.311

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.